Navigation Links
Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
Date:5/31/2009

ents (77.0%) were weaned to every-other-day or less dosing of tacrolimus monotherapy. Among 60 recipients with ACR, the incidence of pre-weaning ACR was 8.5% and post-weaning ACR was 27.9%. At this time, >/= 90% of recipients remain steroid-free on tacrolimus monotherapy.

In a similar study report, Dr. Tan and colleagues performed 478 consecutive unselected living donor kidney transplants using alemtuzumab pre-conditioning and tacrolimus monotherapy. Once again, they used a series of clinical tests including ELISA antibody titers, donor-specific antibodies and the ImmuKnow assay beginning 6 months posttransplant and at 2-6 months intervals. Using these data, tacrolimus was weaned whenever possible. These patients were followed for an average of 35.6 (+/-19.7) months.

Recipient survivals at 1, 2, 3, and 4 years were 98.4%, 95.3%, 93.3%, and 90.4%, respectively. Graft survivals at the same time points were 97.1%, 89.6%, 85.2%, and 77.5%, respectively. The mean (+/-SD) creatinine (mg/dL) after 1, 2 and 3 years were 1.42 (+/-0.61), 1.56 (+/-0.96) and 1.53 (+/-0.83), respectively. The mean (+/-SD) GFR (mL/min/1.73m(2)) at these time points were 59.2 (+/-23.6), 55.0 (+/-21.7) and 53.9 (+/-21.7), respectively. The cumulative incidence of ACR after 1, 3, 6, 12, 18, 24, 30, and 36 months were 1.9%, 3.1%, 4.2%, 9.2%, 14.0%, 16.3%, 18.8% and 19.5%, respectively.

Weaning to every-other-day or less dosing of tacrolimus monotherapy was attempted in 41% of patients. Among 397 patients with functional grafts, 82 (20.6%) are on spaced-dose tacrolimus monotherapy. A total of 114 recipients had ACR. The incidence of pre-weaning ACR was 11.7% and post-weaning was 30.1%. At this time, >/= 80.6% of recipients remain steroid-free on tacrolimus monotherapy.

The use of the ImmuKnow assay as described in these studies has not been cleared by the U.S. Food & Drug Administration.

About Im
'/>"/>

SOURCE Cylex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control
2. Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
3. Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System
4. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
5. AUA Guideline: Full Kidney Removal Not Necessary for All Kidney Tumors
6. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
7. Medgenics Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients
8. DaVita Abstracts Accepted Into National Kidney Foundations 2009 Spring Symposium
9. Freezing Kidney Cancer: Hot Treatment Should Be New Gold Standard for Destroying Small Tumors
10. Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease
11. Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 The potential of the ... of therapeutic agents has been receiving undeniable attention with ... significant promise. The crucial formulation considerations for orally inhaled ... a major role in the efficiency of pulmonary delivery, ... of new formulation techniques and devices in recent years. ...
(Date:5/23/2013)... May 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, ... Annual dbAccess Health Care Conference in Boston.   ... 11:20 a.m. Eastern Time / 8:20 a.m. Pacific Time.  The ... Company,s website at http://www.neurocrine.com . If ...
(Date:5/23/2013)... PAUL, Minn. , May 23, 2013  MGC ... Corporation), a global medical technology company, today scheduled a ... second quarter of fiscal year 2013, ended April 30, ... on Thursday, May 30, 2013. The Company will report ... 2013 after the markets close on Thursday, May 30, ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
... At the 96th Scientific Assembly and Annual Meeting ... November 28 - December 2 in Chicago, Siemens ... will unveil the Biograph™ mMR*, the world,s first ... simultaneous data acquisition technology, currently undergoing clinical use ...
... Schizophrenia is a chronic and disabling brain disorder ... results in substantial medical and societal costs, in particular ... devastating health-related and social effects on people with the ... analysis from a longer-term clinical study presented at the ...
Cached Medicine Technology:Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition 2Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition 3Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 2Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 3Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 4Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 5Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 6
(Date:5/25/2013)... (PRWEB) May 25, 2013 Many orthodontists ... but wonder where exactly that cloud is. Most ... signing up with to provide their cloud service and ... that provide the service they're selling, they'd be wrong. ... center (a secure, redundant facility that houses servers ...
(Date:5/25/2013)... Los Angeles, CA (PRWEB) May 25, 2013 ... for both its effectiveness and results. This is due to ... these breathable adhesive patches. Slim weight patch offers an extra ... your weight loss, fitness goals and get the body you ... Slim Weight Patch Official Website , With Slim weight ...
(Date:5/25/2013)... 2013 Ayurveda is the traditional ... of life". While a medical science, its scope enters into ... Its fundamental philosophy is that disease is the end result ... to re-establish optimal health, one must discover where we are ... which brings us back into perfect harmony. , The Foundations ...
(Date:5/25/2013)... 2013 HealthCrave Medical Centers introduces ... in that it doesn’t just focus on making ... what causes the noticeable signs of aging to ... D. Weiss, M.D., the center provides safe and ... helping patients to live longer, healthier lives. ...
(Date:5/24/2013)... St. Petersburg, FL (PRWEB) May 25, 2013 ... new Cellulite Whisperer ® products from Sublime Beauty®. ... that work to diminish cellulite, and many of the ... tough to deal with and is dreaded by many ... with a concentrated holistic plan, women can diminish their ...
Breaking Medicine News(10 mins):Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Slim Weight Patch Advanced Weight Loss System Offers Extra Two Month Supply and Membership for Maximum Weight Loss 2Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2Health News:Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within 2Health News:"Get Ready for Summer Sale" at Sublime Beauty® Continues: New Cellulite Whisperer® Products 2
... disparities in children; adolescents -ST. LOUIS, April 7 ... today that it awarded a $25,000 grant to ... Alexandria, Indiana to support the School Based ... the effects of inaccessible primary health care for ...
... disorder, study finds , , TUESDAY, April 7 (HealthDay News) ... associated with an increased risk of a vision-threatening complication ... fluid accumulation in the retina. , Glitazones are a ... as pioglitazone (Actos) and rosiglitazone (Avandia). , The U.S. ...
... The Detroit Wayne County Health Authority has begun ... expedite the screening and enrollment of prospective Medicaid ... by TriHealix, a health care technology firm based ... to connect uninsured patients to the right assistance ...
... Fla., April 7 To help facilitate ... professionals and,Hispanic patients, Transitions Optical has developed ... This free bilingual guide illustrates key steps ... between eyecare professionals and,their patients to help ...
... old song goes but violent video games, a new Tel ... teens who play them. , "As a father and brain ... and playing video games," says Dr. Uri Polat of Tel Aviv ... to carry out the new study. "What we see now is ...
... Nonprofit Expertise to National OrganizationSPRINGFIELD, Va., April 7 ... national organization dedicated to supporting those affected by ... it has selected Christine Brown to be its ... nonprofit management, program development, fundraising and advocacy relations ...
Cached Medicine News:Health News:Centene Foundation for Quality Healthcare Awards Grant to Community Health Center 2Health News:Certain Diabetes Drugs May Pose Eye Risk 2Health News:Health Authority Offers Expedient, Web-Based Medicaid Enrollment Service 2Health News:Health Authority Offers Expedient, Web-Based Medicaid Enrollment Service 3Health News:Free Bilingual Eye Exam Guide Now Available to Eyecare Professionals 2Health News:Free Bilingual Eye Exam Guide Now Available to Eyecare Professionals 3Health News:Violent video games can improve vision 2Health News:The National PKU Alliance Expands Leadership and Names Christine Brown as Executive Director 2Health News:The National PKU Alliance Expands Leadership and Names Christine Brown as Executive Director 3
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
... with concave seats and large backrests with ... backrests, armrests, and casters and glides. • ... in a variety of environments including: industry, ... care and office. • With tubular base ...
... ergonomic chairs with concave seats and large ... like seats, backrests, armrests, and casters and ... top performance in a variety of environments ... control, health care and office. • With ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Medicine Products: